Atlas Trials

Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

Clinical trial NCT04531527 · COMPLETED

Trial details

NCT number
NCT04531527
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dermatitis, Phototoxic
Start date
2013-06-24
Primary completion
2013-06-28
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.